Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2013 (2013), Article ID 165014, 5 pages
http://dx.doi.org/10.1155/2013/165014
Clinical Study

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications

1Division of Medicine, Hospital Carabineros of Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile
2Instituto de BioOncología, Avenida Salvador 95, Oficina 95, Providencia, 7500710 Santiago, Chile
3Circulating Tumor Cell Unit, Faculty of Medicine Universidad Mayor, Renato Sánchez 4369, Las Condes, 7550224 Santiago, Chile
4Faculty of Medicine, Universidad Diego Portales, Manuel Rodriguez Sur 415, 8370179 Santiago, Chile
5Urology Service, Hospital Carabineros of Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile
6Radiotherapy, Fundación Arturo López Pérez, Rancagua 899, Providencia, 7500921 Santiago, Chile

Received 9 December 2012; Revised 3 March 2013; Accepted 23 March 2013

Academic Editor: Thomas Rutherford

Copyright © 2013 Nigel P. Murray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Ashworth, “A case of cancer in which cells similar to those in the tumours were seen in the blood after death,” Medical Journal of Australia, vol. 14, pp. 146–149, 1869. View at Google Scholar
  2. W. J. Allard, J. Matera, M. C. Miller et al., “Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases,” Clinical Cancer Research, vol. 10, no. 20, pp. 6897–6904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Pantel, E. Denéve, D. Nocca et al., “Circulating epitelial cells in patients with benign colon diseases,” Clinical Chemistry, vol. 58, no. 5, pp. 936–940, 2012. View at Publisher · View at Google Scholar
  4. S. D. Mikolajczyk, L. S. Millar, P. Tsinberg et al., “Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood,” Journal of Oncology, vol. 2011, Article ID 252361, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Zhou, A. M. Chinnaiyan, C. G. Kleer, P. C. Lucas, and M. A. Rubin, “Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions,” American Journal of Surgical Pathology, vol. 26, no. 7, pp. 926–931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Beach, A. M. Gown, M. N. De Peralta-Venturina et al., “P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies,” American Journal of Surgical Pathology, vol. 26, no. 12, pp. 1588–1596, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. N. P. Murray, G. M. Calaf, L. Badinez et al., “P504S expressing prostate cells as a marker for prostate cancer,” Oncology Reports, vol. 24, no. 3, pp. 689–692, 2010. View at Google Scholar
  8. N. P. Murray, E. Reyes, P. Tapia et al., “Diagnostic performance of malignant prostate cells detected in blood for early detection of prostate cancer: comparison to prostatic biopsy,” Archivos Españoles de Urología, vol. 64, no. 10, pp. 961–971, 2011. View at Google Scholar
  9. A. Ouzzane, P. Coloby, J. P. Mignard et al., “Guidelines for prostatic biopsies best practice,” Progres en Urologie, vol. 21, no. 1, pp. 18–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Borgen, B. Naume, J. M. Nesland et al., “Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells: the European ISHAGE working group for Standardization of Tumor Cell Detection,” Cytotherapy, vol. 1, no. 5, pp. 377–388, 1999. View at Google Scholar · View at Scopus
  11. M. A. Rubin, M. Zhou, S. M. Dhanasekaran et al., “Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer,” Journal of the American Medical Association, vol. 287, no. 13, pp. 1662–1670, 2002. View at Google Scholar · View at Scopus
  12. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. W. Davis, H. Nakanishi, V. S. Kumar et al., “Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer,” Journal of Urology, vol. 179, no. 6, pp. 2187–2191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Eschwège, S. Moutereau, S. Droupy et al., “Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study,” British Journal of Cancer, vol. 100, no. 4, pp. 608–610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Stott, R. J. Lee, S. Nagrath et al., “Isolation and characterization of cir­culating tumor cell from patients with localized and metastatic prostate cancer,” Science Translational Medicine, vol. 2, no. 25, p. 25, 2010. View at Publisher · View at Google Scholar
  16. N. Thiounn, F. Saporta, T. A. Flam et al., “Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases,” Urology, vol. 50, no. 2, pp. 245–250, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. F. A. W. Coumans, C. J. M. Doggen, G. Attard, J. S. de Bono, and L. W. M. M. Terstappen, “All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer,” Annals of Oncology, vol. 21, no. 9, pp. 1851–1857, 2010. View at Publisher · View at Google Scholar · View at Scopus